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Saponins are detergent-like substances showing antibacterial as well as anticancer potential. In this study, the eﬀects of saponins
from Quillaja saponaria were analyzed against prokaryotic and eukaryotic cells. Multidrug-resistant clinical E. coli strains were
isolatedfromhumanurine.Aseukaryoticcells,theCHO-K1celllineswereapplied.Antibacterialeﬀectofampicillin,streptomycin,
and ciproﬂoxacin in the presence of saponins was measured by cultivation methods. Properties of saponins against CHO-K1 cells
were measured by the MTT test, hemolysis assay and ﬂow cytometry. Saponin from Quillaja saponaria has a cytotoxic eﬀect at
concentrations higher than 25μg/mL and in the range of 12–50μg/mL signiﬁcantly increases the level of early apoptotic cells.
Saponin at dose of 12μg/mL enhances the six E. coli strains growth. We postulate that saponins increase the inﬂux of nutrients
from the medium into E. coli cells. Saponins do not have synergetic eﬀects on antibacterial action of tested antibiotics. In contrary,
in the presence of saponins and antibiotics, more CFU/mL E. coli cells were observed. This eﬀect was similar to saponins action
alone towards E. coli cells. In conclusion, saponins was cytotoxic against CHO-K1 cells, whereas against E. coli cells this eﬀect was
not observed.
1.Introduction
Saponins contain a steroidal or a triterpenoid aglycone to
which one or more sugar chains are attached [1]. These
chemical structures determine their biological properties as
natural nonionic detergents which have cytotoxic, hemo-
lytic, molluscicidal, anti-inﬂammatory, antifungal, antiyeast,
antibacterial, and antiviral activities [2–4]. Saponins are
nonionic detergents belonging to the group of glycosides.
They are used in the pharmaceutical industry because some
forms are the starting point for the semisynthesis of steroidal
drugs. Many have pharmacological properties and are used
in phytotherapy and in the cosmetic industry. Saponins can
be classiﬁed into two groups based on the nature of their
aglycone skeleton: steroidal (consisting of a C27 spirostane
skeleton comprising a six-ring structure) and triterpenoid
(consisting of a C30 skeleton comprising a pentacyclic
structure) [1]. The biological properties of saponins depend
on the structure of the aglycone and/or the number of sugar
units involved [5]. The therapeutic potential of saponins
against eukaryotic cells is associated with their cell mem-
brane-permeabilizing properties by complexing with choles-
terol [6]. Our previous studies with a series of synthetic
saponins showed their potential as anticancer drugs [7]. Sap-
onins, having surface-active properties, might insert into the
lipidbilayer,bindtocholesterol,formdomainsenrichedwith
cholesterol-saponin complexes, and ﬁnally lyse cells [8]. On
the other hand, the absence of cholesterol in the membrane
structure does not inhibit pore formation by saponins [9,
10]. In our previous study, we suggested that saponin might
disturb the permeability of the bacterial outer membrane.
About 90% of the surface of naturally cholesterol-free Gram-
negative bacteria cell-wall outer membranes are covered by
lipopolysaccharide (LPS). We concluded that saponin might2 Journal of Biomedicine and Biotechnology
interact with the lipid A part of Proteus LPSs and thereby
increase the permeability of bacterial cell wall. Lipid A-sap-
onin complexes might promote antibiotic (colistin, ampi-
cillin) uptake to inherently resistant bacteria cells [11].
The potentially antibacterial eﬀect of saponins from clin-
ical point of view is associated with a comprehensive inves-
tigation of its antibacterial eﬀect and minimal cytotoxic pro-
pertiesineukaryoticcells.Wepreviouslyshowedthatcolistin
or ampicillin in the presence of 15μg/mL saponins reduced
the numbers of cells of the laboratory strains P. mirabilis
S1959 and R45 [11]. An important medical problem is the
eliminationofpathogenicGram-positiveandGram-negative
bacterial strains. Several types of actions are published, such
asbacteriophagetreatment[12],inhibitionofbacterialadhe-
sion [13], and increasing the permeability of bacterial cell
walls [14].
The aims of the present study are
(i) testing the saponin abilities to induce hemolytic and
cytotoxic eﬀects against eukaryotic cells,
(ii) studies of saponin inﬂuences on growth of clinical
E. coli strains,
(iii) testing of saponin abilities to interfere with antibiotic
action against E. coli cells.
2.MaterialandMethods
2.1. Chemicals. Saponin from Quillaja saponaria bark was
obtainedfromSigmaChemicalCo.,St.Louis,MO,USA.The
main aglycone (sapogenin, 20–35%) moiety is quillaic acid,
a triterpene of predominantly 30 carbon atoms of the 12-
oleanane type. The aglycone is bound to various sugars, in-
cluding glucose, glucuronic acid, galactose, xylose, apiose,
rhamnose, fucose, and arabinose.
2.2. Cell Culture. CHO-K1 cells were cultured at 37◦C
in a humidiﬁed 5% CO2 atmosphere in plastic dishes in
McCoy’s 5A medium supplemented with 10% heat-inacti-
vated fetal calf serum, 2mM L-glutamine, and antibiotics
(100units/mL penicillin and 100μg/mL streptomycin).
2.3. MTT Test. Saponin at ﬁnal concentrations of 12 to
100μg/mL was added to 500μl of the CHO-K1 cell suspen-
sion (1.5 × 106/mL of complete McCoy’s 5A medium) onto
plates. CHO-K1 cells were treated with saponin for 72 hours
at 37◦Ci n5 %C O 2. After treatment, the viability of cells was
evaluated by the MTT assay. MTT reagent was added to each
plate, and after 6h of incubation in Hera Cell, 1mL of SDS
(10% in 0.01N HCl) was added to dissolve the water-insolu-
ble formazan salt. One hour later, the OD650 nm-OD570 nm
diﬀerence was measured. Unexposed cells were regarded as
100% viable [15].
2.4. Apoptosis. CHO-K1 cells were treated with saponin at
diﬀerent concentrations (6, 12, 24, and 50μg/mL) for 72
hours. After treatment, the frequencies of early apoptotic,
late apoptotic, and necrotic cells were evaluated with the
Annexin V-FITC apoptosis detection Kit I (BD Pharmingen,
USA) described elsewhere [16]. Brieﬂy, the cells were washed
twotimeswithcoldPBSandthenresuspendedina1 ×bind-
ing buﬀer at a concentration of 1 × 106cells/mL. An aliquot
of 125μL of the cell suspension was incubated with 5μLo f
Annexin V-FITC and 5μL of propidium iodide (PI) at room
temperature for 15min in the dark. The cells were resus-
pended in 400μLo f1× binding buﬀer. The ﬂuorescence was
determined using a Becton Dickinson FACSscan ﬂow cyto-
meter. A computer system (CellQuest Pro, Becton Dickin-
son) was used for data acquisition and analysis. Data for
20000eventswerestored.AcellgatecontainingCHO-K1was
establishedonthebasisofforwardandsidelightscatter.Four
diﬀerent populations of cells were detected with the Annexin
V-FITCkit:normalcellsthatareAnnexinnegativeandPIne-
gative and express no ﬂuorescence, early apoptotic cells that
are Annexin positive and PI negative and express green ﬂu-
orescence, late apoptotic/necrotic cells that are Annexin pos-
itive and PI positive and express green and orange ﬂuores-
cence, and necrotic cells that are Annexin negative and PI
positive and express orange ﬂuorescence.
2.5. Hemolysis Assay. Blood was obtained from healthy
young male donors. The red blood cells (RBCs) were washed
threetimesandresuspendedinsterilePBStogiveabout15 ×
106 cellspermLandfurtherprocessed[17].Theerythrocytes
were incubated with saponin in a range of 0.5–50μg/mL for
1hat37 ◦C. After centrifugation of the nonhemolysed eryth-
rocytes (1400rpm, 15min), the absorbance of the released
hemoglobin in the wavelength range of 400–600nm was
measured. The percentage of hemolysis was determined by
comparing the absorbance of hemoglobin at 435, 540, and
575nm released from the RBCs in the presence of saponin.
The positive control (100% hemolysis) was determined by
theamountofhemoglobinreleasedfrom15 ×106 RBCsafter
10min of incubation with water.
2.6. Bacteria Growth in the Presence of Saponin and Antibi-
otics. Six strains of E. coli isolated from patients at the
Department of Microbiology, Holy Cross Cancer Center in
Kielce, Poland, were included in this study. The stock solu-
tion of saponin (Sigma Chemical Co., St. Louis, MO, USA)
wasdilutedinLBmediumorminimalM9mediumdescribed
elsewhere [18]. The reaction mixtures contained saponin at
concentrations of 0.1–12μg/mL and a bacterial suspension
of E. coli strains at 102 cells/mL in each probe in ﬁnal volu-
mes of 300μl of proper medium. Incubation was carried out
for 18h at 37◦C. Bacterial viability was expressed in terms
of colony-forming units (CFU/mL). Additionally, the anti-
microbial susceptibility of the clinical E. coli strains to ampi-
cillin, streptomycin, and ciproﬂoxacin at 25–400μg/mL was
prospectively tested in the presence of saponin at 12μg/mL
in LB medium by the cultivation methods.
2.7. Data Analysis. The data were analyzed using the Sta-
tistica software package (StatSoft, Tulsa, OK, USA). All the
values in this study are expressed as the mean ± SD of three
experiments. If no signiﬁcant diﬀerences between variationsJournal of Biomedicine and Biotechnology 3
Table 1: Percentage of early and late apoptotic and necrotic CHO-K1 cells following treatment with saponin measured by ﬂow cytometry;
mean of three experiments ± SD. IP: propidium iodide.
Saponin (μg/mL) Normal cells (Annexin−/IP−) Apoptosis Necrosis (Annexin−/IP+)
Early (Annexin+/IP−) Late (Annexin+/IP+)
09 6 .08 ±0.07 0.07 ±0.06 2.53 ±0.06 0.69 ±0.06
12 85.75 ±0.62 5.99 ±0.33 6.21 ±0.19 2.06 ±0.13
25 79.73 ±2.52 18.67 ±2.49 1.89 ±0.04 0.70 ±0.04
50 64.59 ±0.32 30.88 ±0.10 2.09 ±0.16 2.52 ±0.17
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Figure 1: Percentage of the viability of CHO-K1 cells following treatment with saponin measured by the MTT assay; mean of three
experiments ± SD. ∗P<0.005.
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Figure 2: Hemolysis of human erythrocytes incubated with sap-
onin. Hemolysis was measured at 435, 540, and 570nm; mean of
three independent experiments ± SD. ∗P<0.005.
were found as assessed by the Snedecor-Fisher test, the
differences were compared by the ANOVA test.
3. Results
3.1. The Eﬀect of Saponin on Eukaryotic Cells
3.1.1. Drug Resistance. Figure 1 shows the percent viability
of the CHO-K1 cells after 4-day treatment with saponin at
concentrations ranging from 12 to 100μg/mL measured by
the MTT assay. It was found that saponin at concentrations
25 and 50μg/mL caused 70% and 50% cell killing, respec-
tively.
3.1.2. Apoptosis. Table 1 shows the level of apoptosis mea-
sured by ﬂow cytometer with the Annexin V-FITC kit and
propidium iodide staining according to [16]. Saponin dose-
depended lyses of CHO-K1 cells were observed, as in MTT
test (Figure 1). The number of early and late apoptotic cells
was detected after incubation with saponin in a concentra-
tion range of 12–50μg/mL. The ﬂow cytometric analyses
of the CHO-K1 cells population showed that saponins at
concentrations of 12–50μg/mL signiﬁcantly increased the
percentage of early apoptotic cells up to 30.88%. It was in
a saponin dose-dependent manner compared with the un-
treated control. The increase in the number (6.21%) of late
apoptosis was notice at the dose of 12μg/mL of saponin. The
necrosis of cells varied and did not excite 2.52% at saponin
dose 50μg/mL.
3.1.3. Hemolysis Assay. In addition to CHO-K1 cell line, the
human red blood cells (RBCs) were used as hemolysis mark-
er. Figure 2 shows the amount of hemoglobin released from
RBCsthatwasdeterminedbytheabsorbanceat435,540,and
575nm in the presence of saponin at concentrations ranging
from 3 to 100μg/mL. We observed a statistically signiﬁcant,
dose-depended increase in hemolysis at concentrations from
25 up to 100μg/mL. The proportion of pick at 435, 540, and
575nm was similar. This may suggest that porﬁrine rings
and iron molecules are not released from hemoglobin, and
observed hemolysis is the eﬀect of RBCs wall destruction.4 Journal of Biomedicine and Biotechnology
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Figure 3: The eﬀect of saponin on the growth of the E. coli strains incubated for 18h at 37◦C in LB (a) and M9 medium (b); mean of three
independent experiments ± SD. ∗P<0.005.
Thesaponininrange3–12μg/mLdoesnotinducehemolysis.
This indicates that critical amount of saponin molecules
25μg/mL is required to destabilize cell wall of erythrocytes.
3.2. The Eﬀect of Saponin on Bacterial Cells
3.2.1. The Eﬀect of Saponin on Bacterial Growth. Figure 3(a)
shows the eﬀect of saponin at concentrations ranging from 1
to 12μg/mL onthe growth of the six clinical E.colistrains in-
cubated for 18h at 37◦Ci nL Bm e d i u m .T h ep r e s e n c eo f
saponin does not inhibite E.coli c e l l sg r o w t h .I ti sw o r t ht o
notice that we observed statistically signiﬁcant increases in
CFU of the multidrug resistant- (MDR-) E. coli strains in the
presence of saponin at a concentration of 6 and 12μg/mL in
LB medium, in contrast to growth of bacterial strains in M9
medium which was inﬂuenced by saponin presence (Figure
3(b)).
3.2.2. The Eﬀect of Saponin and Antibiotics on Bacterial
Growth. In next experiment, dose of 12μg/mL of saponin in
LB medium was used for testing antibiotic action against E.
coli cells. Figure 4 shows the eﬀect of the presence of saponin
and ampicillin, streptomycin, or ciproﬂoxacin at concentra-
tions ranging from 25 to 400μg/mL on the growth of the
clinical E. coli strains incubated for 18h at 37◦Ci nL Bm e d -
ium. All six strains were sensitive to ciproﬂoxacin and resis-
tant to ampicillin and streptomycin. The addition of saponin
caused in strains 3 and 6 that ciproﬂoxacin was less eﬀective
(Figure 4 compares open circle and open triangle). Having a
similareﬀect,increasesofamountofcellswereobservedwith
ampicillin or streptomycin and saponin mixtures in all
strainstested(blackorgraycircleandtriangle,Figure 4).The
presented results indicate that saponin enhances clinical E.
coli cells growth in the presence of antibiotics.
4. Discussion
Medically desired situation is the concentration of saponins
with antibacterial properties that has minimal cytotoxic acti-
vity against eukaryotic cells. Saponins possess detergent-like
properties and might increase the permeability of bacterial
cellmembraneswithoutdestroyingthem[19].Intheory,this
activity might facilitate antibiotic inﬂux through the bacte-
rial cell wall membrane. In the presented studies, we com-
pared saponins’ activities against prokaryotic and eukaryotic
cells. We used commercial saponin from Quillaja saponaria,
which is one of the major sources of industrial triterpenoid
saponins. Saponins extracts from Quillaja saponaria have
been in practical use as foaming agents in beverages or emul-
siﬁers in foods [20]. In our investigations, we analyzed the
activity of saponin from Quillaja saponaria against CHO-K1
cell line. The saponin extracts increase the number of early
apoptoticcellsinadose-dependentmanner.Saponinsdonot
inducesigniﬁcantlynecrosisandlateapoptosis. Eﬀectofsap-
onin on membrane receptors for apoptosis was shown also
byothers[5].Inourstudies,wealsohaveshownthatsaponin
at concentrations higher than 12μg/mL has signiﬁcantly cy-
totoxic eﬀect on CHO-K1 cells. Similar eﬀect was observed
with human erythrocytes at dose 25μg/mL of saponins. In-
terestingly,lowerdosesdonotlyseofRBCatall.Thatmayin-
dicate a deﬁned amount of saponins intercalating to cell wall
membranes of erythrocytes needed to lyse it. To analyze
the antibacterial properties of saponin, we use saponin at
12μg/mL taking into consideration its minimal cytotoxic ef-
fectagainsteukaryoticcells.SaponindoesnotinhibitesE.coli
growth in minimal M9 and Luria broth. In contrary, we ob-
served statistically signiﬁcant increases in CFU/mL of six
tested MDR E. coli strains in the presence of saponin at a
concentration of 12μg/mL. This eﬀect was not observed on
bacterial growth in M9 minimal medium. Our study of
analysis of susceptibility of clinical E. coli strains against
ampicillin, streptomycin, and ciproﬂoxacin in presence ofJournal of Biomedicine and Biotechnology 5
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Figure 4: The eﬀect of saponin at 12μg/mL and ampicillin, streptomycin, or ciproﬂoxacin at concentrations ranging from 25 to 400μg/mL
on the growth of the E. coli strains incubated for 18h at 37◦C in LB medium; mean of three independent experiments ± SD.
saponin at a concentration of 12μg/mL conﬁrmed that sap-
onins enhance bacteria growth, even in antibiotic presence.
In conclusion, we presented varied potencies of saponins
against eukaryotic and prokaryotic cells. That is probably
due to diﬀerences on cell membranes of two cell types.
The biological properties of chemical substances potentially
useful in clinical use should be characterized by their deﬁned
activity in correlation with the optimal concentration.6 Journal of Biomedicine and Biotechnology
Acknowledgments
The work was supported by a Grant no. N N304 044639. The
authors would like to thank Bonita Durna´ s from the Depart-
ment of Microbiology, Holy Cross Cancer Center in Kielce,
Poland, for the collected E. coli strains and Marta Kowalik,
Marianna Jag´ odka, and Katarzyna Pastuszka for technical
support.
References
[1] S. G. Sparg, M. E. Light, and J. Van Staden, “Biological activit-
ies and distribution of plant saponins,” Journal of Ethnophar-
macology, vol. 94, no. 2-3, pp. 219–243, 2004.
[2] Y.M.Leung,Y.J.Ou,C.Y.Kwan,andT.T.Loh,“Speciﬁcinter-
action between tetrandrine and Quillaja saponins in promot-
ingpermeabilizationofplasmamembraneinhumanleukemic
HL-60cells,”BiochimicaetBiophysicaActa,vol.1325,no.2,pp.
318–328, 1997.
[ 3 ]S .S e n ,H .P .S .M a k k a r ,S .M u e t z e l ,a n dK .B e c k e r ,“ E ﬀect of
Quillaja saponaria saponins and Yucca schidigera plant extract
on growth of Escherichia coli,” Letters in Applied Microbiology,
vol. 27, no. 1, pp. 35–38, 1998.
[4] C. Bachran, M. Sutherland, I. Heisler, P. Hebestreit, M. F.
Melzig, and H. Fuchs, “The saponin-mediated enhanced up-
take of targeted saporin-based drugs is strongly dependent
on the saponin structure,” Experimental Biology and Medicine,
vol. 231, no. 4, pp. 412–420, 2006.
[5] M. Chwalek, N. Lalun, H. Bobichon, K. Pl´ e, and L. Vout-
quenne-Nazabadioko, “Structure-activity relationships of
some hederagenin diglycosides: haemolysis, cytotoxicity and
apoptosis induction,” Biochimica et Biophysica Acta, vol. 1760,
no. 9, pp. 1418–1427, 2006.
[6] H. G¨ ogelein and A. H¨ uby, “Interaction of saponin and
digitonin with black lipid membranes and lipid monolayers,”
Biochimica et Biophysica Acta, vol. 773, no. 1, pp. 32–38, 1984.
[7] H. Myszka, D. Bednarczyk, M. Najder, and W. S. Kaca, “Syn-
thesis and induction ofapoptosis inBcell chronic leukemia by
diosgenyl 2-amino-2-deoxy-β-D-glucopyranoside hydrochlo-
ride and its derivatives,” Carbohydrate Research, vol. 338, no.
2, pp. 133–141, 2003.
[8] E. Baumann, G. Stoya, A. V¨ olkner, W. Richter, C. Lemke, and
W. Linss, “Hemolysis of human erythrocytes with saponin
aﬀects the membrane structure,” Acta Histochemica, vol. 102,
no. 1, pp. 21–35, 2000.
[9] R. Segal, P. Shatkovsky, and I. Milo Goldzweig, “On the mech-
anism of saponin hemolysis. I. Hydrolysis of the glycosidic
bond,” Biochemical Pharmacology, vol. 23, no. 5, pp. 973–981,
1974.
[10] W. P. Winter, “Mechanism of saponin induced red cell hemol-
ysis: evidence for the involvement of aquaporin CHIP28,”
Blood, vol. 84, supplement 1–10, abstract 445, 1994.
[11] M. Arabski, S. Wasik, K. Dworecki, and W. Kaca, “Laser inter-
ferometric and cultivation methods for measurement of co-
listin/ampicilin and saponin interactions with smooth and
rough of Proteus mirabilis lipopolysaccharides and cells,” Jour-
nal of Microbiological Methods, vol. 77, no. 2, pp. 178–183,
2009.
[12] S. O’Flaherty, R. P. Ross, and A. Coﬀey, “Bacteriophage and
their lysins for elimination of infectious bacteria: Review ar-
ticle,” FEMS Microbiology Reviews, vol. 33, no. 4, pp. 801–819,
2009.
[13] B. Montdargent and D. Letourneur, “Toward new biomateri-
als,”InfectionControlandHospitalEpidemiology,vol.21,no.6,
pp. 404–410, 2000.
[14] L.Mamelli,S.Petit,J.Chevalieretal.,“Newantibioticmolecu-
les: bypassing the membrane barrier of gram negative bacteria
increases the activity of peptide deformylase inhibitors,” PLoS
ONE, vol. 4, no. 7, article e6443, 2009.
[15] I. Majsterek, M. Arabski, A. Czechowska et al., “Imatinib
(STI571) inhibits DNA repair in human leukemia oncogenic
tyrosinekinase-expressingcells,”ZeitschriftfurNaturforschung
C, vol. 61, no. 11-12, pp. 896–902, 2006.
[16] Z.Darzynkiewicz,CurrentProtocolsinCellBiology,J ohnW iley
& Sons, 2003.
[17] M. Arabski, K. Gwo´ zdzinski, B. Sudak, and W. Kaca, “Eﬀects
of Proteus mirabilis lipopolysaccharides with diﬀerent O-poly-
saccharide structures on the plasma membrane of human
erythrocytes,”ZeitschriftfurNaturforschungC,v ol.63,no .5-6,
pp. 460–468, 2008.
[ 1 8 ]J .S a m b r o o ka n dD .W .R u s s e l l ,Molecular Cloning: A Labora-
toryManual,ColdSpringHarborLaboratoryPress,NewYork,
NY, USA, 3rd edition, 1989.
[19] M. C. Jacob, M. Favre, and J. C. Bensa, “Membrane cell per-
meabilisation with saponin and multiparametric analysis by
ﬂow cytometry,” Cytometry, vol. 12, no. 6, pp. 550–558, 1991.
[20] D. Pelah, Z. Abramovich, A. Markus, and Z. Wiesman, “The
use of commercial saponin from Quillaja saponaria bark as a
natural larvicidal agent against Aedes aegypti and Culex pip-
iens,” Journal of Ethnopharmacology, vol. 81, no. 3, pp. 407–
409, 2002.